paliperidon-ratiopharm 150 mg depot-injektionssuspension
paliperidon-ratiopharm 100 mg depot-injektionssuspension
dimethyl fumarate teva
teva gmbh - dimethyl fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressants - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv)
ajovy
teva gmbh - fremanezumab - migraine disorders - calcitonin gene-related peptide (cgrp) antagonists - ajovy is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
captohct-ratiopharm tablets 25/12.5mg milligram
ratiopharm gmbh - captopril hydrochlorothiazide - tablets - 25/12.5mg milligram
captohct-ratiopharm tablets 50/25mg milligram
ratiopharm gmbh - captopril hydrochlorothiazide - tablets - 50/25mg milligram
captopril-ratiopharm tablets 12.5 milligram
ratiopharm gmbh - captopril - tablets - 12.5 milligram
captopril-ratiopharm tablets 25 milligram
ratiopharm gmbh - captopril - tablets - 25 milligram
captopril-ratiopharm tablets 50 milligram
ratiopharm gmbh - captopril - tablets - 50 milligram